QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: mol.105.014985v1 69/1/45    most recent Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hague, C. Articles by Minneman, K. P. Search for Related Content PubMed PubMed Citation Articles by Hague, C. Articles by Minneman, K. P.

Heterodimers of _1B- and _1D-Adrenergic Receptors Form a Single Functional Entity

Department of Pharmacology, Emory University School of Medicine, Atlanta, Georgia

Heterologous expression of _1D-adrenergic receptors (_1D-ARs) in most cell types results in intracellular retention and little or no functionality. We showed previously that heterodimerization with _1B-ARs promotes surface localization of _1D-ARs. Here, we report that the _1B-/_1D-AR interaction has significant effects on the pharmacology and signaling of the receptors, in addition to the effects on trafficking described previously. Upon coexpression of _1B-ARs and epitope-tagged _1D-ARs in both human embryonic kidney 293 and DDT₁MF-2 cells, _1D-AR binding sites were not detectable with the _1D-AR selective antagonist 8-[2-(4-(2-methoxyphenyl)piperazin-1-yl)ethyl]-8-azaspiro[4,5]decane-7,9-dione (BMY 7378), despite the ability to detect _1D-AR protein using confocal microscopy, immunoprecipitation, and a luminometer cell-surface assay. However, the _1B-AR-selective mutant F18A conotoxin showed a striking biphasic inhibition in _1B/_1D-AR-expressing cells, revealing that _1D-ARs were expressed but did not bind BMY 7378 with high affinity. Studies of norepinephrine-stimulated inositol phosphate formation showed that maximal responses were greatest in _1B/_1D-AR-coexpressing cells. Stable coexpression of an uncoupled mutant _1B-AR (12) with _1D-ARs resulted in increased responses to norepinephrine. However, Schild plots for inhibition of norepinephrine-stimulated inositol phosphate formation showed a single low-affinity site for BMY 7378. Thus, our findings suggest that _1B/_1D-AR heterodimers form a single functional entity with enhanced functional activity relative to either subtype alone and a novel pharmacological profile. These data may help to explain why _1D-ARs are often pharmacologically undetectable in native tissues when they are coexpressed with _1B-ARs.

Address correspondence to: Dr. Kenneth P. Minneman, Department of Pharmacology, Emory University School of Medicine, Atlanta, GA 30322. E-mail: kminneman{at}pharm.emory.edu

This article has been cited by other articles:

				J. S. Lyssand, M. C. DeFino, X.-b. Tang, A. L. Hertz, D. B. Feller, J. L. Wacker, M. E. Adams, and C. Hague Blood Pressure Is Regulated by an {alpha}1D-Adrenergic Receptor/Dystrophin Signalosome J. Biol. Chem., July 4, 2008; 283(27): 18792 - 18800. [Abstract] [Full Text] [PDF]

				L. Szidonya, M. Cserzo, and L. Hunyady Dimerization and oligomerization of G-protein-coupled receptors: debated structures with established and emerging functions J. Endocrinol., March 1, 2008; 196(3): 435 - 453. [Abstract] [Full Text] [PDF]

				C. F. Bush, S. V. Jones, A. N. Lyle, K. P. Minneman, K. J. Ressler, and R. A. Hall Specificity of Olfactory Receptor Interactions with Other G Protein-coupled Receptors J. Biol. Chem., June 29, 2007; 282(26): 19042 - 19051. [Abstract] [Full Text] [PDF]

				J.-P. Pin, R. Neubig, M. Bouvier, L. Devi, M. Filizola, J. A. Javitch, M. J. Lohse, G. Milligan, K. Palczewski, M. Parmentier, et al. International Union of Basic and Clinical Pharmacology. LXVII. Recommendations for the Recognition and Nomenclature of G Protein-Coupled Receptor Heteromultimers Pharmacol. Rev., March 1, 2007; 59(1): 5 - 13. [Abstract] [Full Text] [PDF]

				S. C. Prinster, T. G. Holmqvist, and R. A. Hall {alpha}2C-Adrenergic Receptors Exhibit Enhanced Surface Expression and Signaling upon Association with beta2-Adrenergic Receptors J. Pharmacol. Exp. Ther., September 1, 2006; 318(3): 974 - 981. [Abstract] [Full Text] [PDF]

				A. M. Finch and R. M. Graham The {alpha}1D-Adrenergic Receptor: Cinderella or Ugly Stepsister Mol. Pharmacol., January 1, 2006; 69(1): 1 - 4. [Abstract] [Full Text] [PDF]